Vor Biopharma

Cambridge, United States

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

$75.0M raised

Mar 2026

Post-IPO Equity

Biotechnology Health Care Oncology Pharmaceutical

Top Investors

RA Capital Management Qiming Venture Partners TCG Crossover OUP (Osage University Partners)Frazier Life Sciences

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vor Biopharma

How much funding has Vor Biopharma raised?

Vor Biopharma has raised $75.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.

Who are Vor Biopharma's investors?

Vor Biopharma's investors include RA Capital Management, Qiming Venture Partners, TCG Crossover, OUP (Osage University Partners), Frazier Life Sciences.

Where is Vor Biopharma headquartered?

Vor Biopharma is headquartered in Cambridge, United States.

What does Vor Biopharma do?

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

What stage is Vor Biopharma at?

Vor Biopharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 27, 2026.

MLA

"Vor Biopharma — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/vor-biopharma. Accessed July 2, 2026.

APA

VCBacked. (2026). Vor Biopharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vor-biopharma

Wikipedia (cite web)

{{cite web |title=Vor Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/vor-biopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 27, 2026.